Skip to main content

Table 2 Effect of BMGlvA2 on inflammatory cytokines and metabolic indicators in serum

From: Bombyx mori gloverin A2 alleviates enterotoxigenic Escherichia coli-induced inflammation and intestinal mucosa disruption

Indicators

-K88

+K88

P value

0.0 mg/kg

4.0 mg/kg

8.0 mg/kg

0.0 mg/kg

4.0 mg/kg

8.0 mg/kg

Interaction

K88

A

IL-1β ng/mL

219.90 ± 0.01

220.10 ± 0.02

220.10 ± 0.03

220.00 ± 0.04

220.10 ± 0.03

220.00 ± 0.02

0.261

0.847

0.371

IL-6 ng/mL

9.14 ± 0.1027b

9.47 ± 0.14b

9.06 ± 0.08b

79.25 ± 4.88a

28.52 ± 5.10b

9.54 ± 0.09b

< 0.0001

< 0.0001

< 0.0001

TNFα ng/mL

215.60 ± 0.07b

215.90 ± 0.16b

215.70 ± 0.08b

230.50 ± 1.68a

218.10 ± 0.70b

215.80 ± 0.10b

< 0.0001

< 0.001

< 0.001

D-LA μg/L

3.27 ± 0.00

3.28 ± 0.01

3.23 ± 0.03

3.32 ± 0.00

3.29 ± 0.01

3.28 ± 0.01

0.261

0.847

0.371

CRP mg/L

4.32 ± 0.17ab

3.93 ± 0.23b

2.67 ± 0.09b

4.70 ± 0.38ab

6.06 ± 0.55a

4.70 ± 0.25ab

0.373

0.010

0.138

TP g/L

60.50 ± 0.61a

58.83 ± 0.23a

55.52 ± 0.24ab

52.50 ± 0.73b

55.87 ± 0.62ab

57.43 ± 0.46ab

0.003

0.008

0.721

GLO g/L

28.47 ± 0.35a

27.67 ± 0.17a

27.10 ± 0.29ab

24.82 ± 0.45b

25.88 ± 0.39b

27.45 ± 0.29a

0.069

0.018

0.724

ALB g/L

32.03 ± 0.28a

31.27 ± 0.10a

29.52 ± 0.25ab

27.68 ± 0.31b

29.98 ± 0.27ab

29.98 ± 0.22ab

0.001

0.001

0.296

A/G

1.13 ± 0.01ab

1.13 ± 0.01ab

1.09 ± 0.01b

1.12 ± 0.012ab

1.16 ± 0.01a

1.09 ± 0.01b

0.654

0.681

0.076

UREA mmol/L

8.07 ± 0.11b

7.81 ± 0.12

7.45 ± 0.07b

26.24 ± 1.66a

7.10 ± 0.09b

8.99 ± 0.07b

< 0.0001

0.0004

< 0.0001

CREA μmol/L

6.00 ± 0.23b

6.48 ± 0.19ab

7.09 ± 0.19ab

26.25 ± 2.76a

6.65 ± 0.13ab

7.08 ± 0.21ab

0.182

0.113

0.519

ALT U/L

39.83 ± 1.63a

24.40 ± 0.41c

18.60 ± 1.85c

36.33 ± 2.91ab

27.17 ± 0.99bc

24.60 ± 0.39c

0.510

0.609

0.001

AST U/L

303.50 ± 25.74a

147.00 ± 6.33b

174.30 ± 18.02b

325.00 ± 26.54a

131.80 ± 7.45b

249.70 ± 20.66ab

0.596

0.466

0.002

  1. The data were expressed as mean ± SEM. Data with different superscript letters in a row indicated that the differences between different treatment groups were statistically significant (p < 0.05). IL-1β interleukin 1 beta, IL-6 interleukin 6, TNFα tumor necrosis factor alpha, D-LA d-lactic acid, CRP c-reactive protein, TP total protein, GLO globulin, ALB albumin, A/G albumin/globulin, CREA creatinine, ALT alanine aminotransferase, AST glutinous straw transaminase